DG DISPATCH - RSNA: Radiofrequency Ablation Effective For Breast Cancer Liver Metastases
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




DG DISPATCH - RSNA: Radiofrequency Ablation Effective For Breast Cancer Liver Metastases

By Lara Pullen
Special to DG News

CHICAGO, IL -- December 1, 1999 -- There is no established treatment for breast cancer metastases to the liver. A recent study, however, indicates that radiofrequency (RF) ablation is a safe and simple procedure that is an effective treatment for these local hepatic metastases.

At the 85th Annual Meeting of the Radiological Society of North America, in Chicago, IL, Dr. Tito Livraghi, of Vimercate Hospital, in Italy presented the results of a study designed to evaluate the efficacy of RF ablation in breast cancer liver metastases.

The study consisted of 15 lesions in 10 patients (mean age of 51) who were treated at Vimercate Hospital. Eight of these patients had progressive metastatic disease after chemotherapy, while two patients had refused chemotherapy and presented with hepatic metastases only. Patients underwent ultrasound-guided RF ablation using 17-gauge, internally cooled electrodes. Following RF ablation, therapeutic efficacy was evaluated with biphasic helical computed tomography (CT) performed at four-month intervals. Follow-up ranged from four to 30 months.

Complete necrosis was obtained in 14 out of 15 lesions (93 percent). Follow-up imaging studies were unable to detect a recurrence in any of the 14 lesions. Four patients have remained disease free, five developed new hepatic and/or extra-hepatic metastases, and one died with diffuse metastases. RF ablation resulted in no complications.

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities